
⚠️This account isn’t being managed anymore. Follow @ResearchKarger for all Karger #Oncology news and publications.
Basel, Switzerland
Joined March 2020
- Tweets524
- Following49
- Followers842
- Likes157
Oncology | Karger retweeted
📢 We’re thrilled to announce an exciting new partnership with @ByLudenso, aimed at revolutionizing scientific journal content.
By integrating #AugmentedReality (AR) technology, Karger #journals will now offer #authors innovative ways to visualize their #research.
More in the latest #PressRelease 🔗 ow.ly/shSb50Smpis
Oncology | Karger retweeted
Radiogenomic correlations with ccRCC biomarkers
🧬Use of TCGA-KIRC & TCIA-KIRC databases
📈After stratification: predictions of KDM5C, SETD2, PBRM1, & mTOR mutation status showed significant improvements AUC 0.70-0.86
#Radiogenomics @OncoKarger doi.org/10.1159/000530719
Oncology | Karger retweeted
'New #Media Platforms for Teaching and Networking: Emerging Global Opportunities for Breast Surgeons' @OncoKarger #Oncology #Research
scienceopen.com/document?vid…
Oncology | Karger retweeted
'St. Gallen/Vienna 2023: Optimization of #Treatment for Patients with Primary #BreastCancer – A Brief Summary of the Consensus Discussion' @OncoKarger #Oncology
scienceopen.com/document?vid…
Oncology | Karger retweeted
'#Menopausal #Hormone Therapy and the Breast: A Review of Clinical Studies' @OncoKarger #Oncology #Research
scienceopen.com/document?vid…
Oncology | Karger retweeted
'Karger: Oncology' encompasses a selection of #publications on #oncology from across a variety of Karger #books and journals:
@OncoKarger #research
scienceopen.com/collection/5…
Oncology | Karger retweeted
#Regorafenib versus Cabozantinib as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: An Anchored Matching-Adjusted Indirect Comparison of Efficacy and Safety
🔗 ow.ly/zJZ750OZU56
✍ Merle P. et al.
📖 #LiverCancer
@OncoKarger
#HCC #Treatment #Survival
Oncology | Karger retweeted
No predictive value for PAM-50 and ovarian function suppression benefit in SOFT….
Oncology | Karger retweeted
Great plenary wrap-up talk by @AngieDemichele, summarizing adjuvant CDK4/6 intermediate risk subgroup results @ASCO @ABCSGVienna #pallas
Oncology | Karger retweeted
From stomach to skin, from blood to liver – #oncology at @KargerPublisher adopts an interdisciplinary approach and covers all aspects of #cancer with a host of journals and with a strong focus on clinical #research.
Discover 'Karger: Oncology'
scienceopen.com/collection/5…
Oncology | Karger retweeted
Endometrial cancer is the most common cancer of the uterus
Educate yourself with "Fast Facts: Endometrial Cancer" a must-have for healthcare professionals & those seeking to understand the disease
🔗 ow.ly/KQv150MIJOV
#WorldCancerDay #Education #FreeResource
Oncology | Karger retweeted
Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies
📖Pharmacology
✍️Casari C, Novysedlak R, Vachtenheim Jr. J, Lischke R, Strizova Z
#EsophagealCancer #Chemotherapy #Immunotherapy @OncoKarger
ow.ly/3U6a50MzMsP
Oncology | Karger retweeted
Clinical Applications of Optical Coherence #TomographyAngiography in #OcularOncology: Pearls and Pitfalls
➡️ ow.ly/NL8S50LgGOe
✍️ Marco Pellegrini et al.
📖 Ocular Oncology and Pathology
#FreeAccess #ReviewArticle #UvealMelanoma
Oncology | Karger retweeted
New Insights into Macular Type of Primary Cutaneous B-Cell Lymphoma: Extension of the Clinical and Histopathological Patterns
✍ Barzilai A. et al
📖 Dermatology
🔗 ow.ly/ImCv50LKTae
#SkinCancer #Lymphoma #OpenAccess #Dermatology
Oncology | Karger retweeted
Molecular Determinants of Peritoneal Dissemination in Gastric Adenocarcinoma
✍ Valentina Mari and Valentina Angerilli
📑 ow.ly/RP4q50LLP4M
#DigDis #OpenAccess #GastricCancer #OncologicalTreatments #Biomarkers
Oncology | Karger retweeted
Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma
✍ van Delft L.C.J. et al
📖 Dermatology
🔗 ow.ly/xfqw50LKTRX
#SkinCancer #OpenAccess
Oncology | Karger retweeted
Exposure to Air Pollution and Survival in Follow-Up after Hepatocellular Carcinoma
✍ Wei-Shan Chin
📑 ow.ly/PwAN50LIMqN
#LiverCancer #OpenAccess #HCC #AirPollution #CancerMortality #BMI
Oncology | Karger retweeted
Adjunctive Treatment with #Interferon Alpha 2b in #ConjunctivalMelanoma
➡️ ow.ly/N8RX50LgyR8
✍️ Valentín Huerva et al.
📖 Ocular Oncology and Pathology
#FreeAccess #CaseSeries #OcularOncology
Oncology | Karger retweeted
Are you a #researcher looking to play an active role in your community and gain insight into publishing, promotion, communications, and other vital skills for your future in research (or healthcare) & life? Then become a #KargerAmbassador.
Learn more 🔗 ow.ly/e5T050LJuFQ
Oncology | Karger retweeted
From stomach to skin, from blood to liver – #oncology at Karger adopts an #interdisciplinary approach and covers all aspects of #cancer with a host of journals and with a strong focus on clinical research.
Explore @OncoKarger:
scienceopen.com/collection/5…





















